U.S. Renewable Energy Stock News

NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

A Look At Gibraltar Industries (ROCK) Valuation After Renewables Exit And Refocus On Core Businesses

Gibraltar Industries (ROCK) is reshaping its business by divesting its Renewables segment. This move refocuses the company on its core Building Products and Structures segments amid shifting expectations around risk, growth and execution. See our latest analysis for Gibraltar Industries. The recent Renewables divestiture headlines come against a weak price backdrop, with the share price down 26.27% year to date and the 1-year total shareholder return down 38.83%. This suggests fading momentum...
NasdaqGM:APPN
NasdaqGM:APPNSoftware

Do Appian’s (APPN) Conference Messages Clarify or Complicate Its Long-Term Growth Narrative?

In late May 2026, Appian participated in TD Cowen's 54th Annual Technology, Media & Telecom Conference in New York and William Blair's 46th Annual Growth Stock Conference in Chicago, with Chief Financial Officer Srdjan Tanjga presenting the company's latest performance and outlook. These appearances followed a strong first quarter where Appian exceeded revenue expectations yet paired the beat with comparatively cautious full-year guidance, highlighting the tension between current execution...
NYSE:FDXF
NYSE:FDXFTransportation

US Stock Market Today: S&P 500 Futures Slide On Strong Jobs Data And Rate Jitters

The Morning Bull - US Market Morning Update Monday, Jun, 8 2026 US stock futures are pointing sharply lower this morning, with E mini S&P 500 contracts down about 2.6% and Nasdaq 100 futures off nearly 4.8%, as investors react to stronger than expected US jobs data and a jump in market volatility. Nonfarm payrolls rose by 172,000 in May and unemployment held at 4.3%, while wages grew 0.3% month over month, signaling a job market that is still firm and keeping alive the prospect of another...
NYSE:SR
NYSE:SRGas Utilities

A Look At Spire (SR) Valuation After Earnings Reset And Long Term Capital Plan Update

Spire (SR) is back in focus after its latest second quarter update, where adjusted earnings came in slightly below estimates, revenue declined year over year, and management reset 2026 guidance alongside a new long term capital plan. See our latest analysis for Spire. Following the earnings reset and long term capital plan, Spire’s recent share price has been choppy, with the stock down over the past quarter but supported by a 1 year total shareholder return of 16.13% and a 5 year total...
NasdaqGS:BSY
NasdaqGS:BSYSoftware

A Look At Bentley Systems (BSY) Valuation After Q1 2026 Growth And Capital Structure Moves

Bentley Systems (BSY) drew fresh investor attention after reporting Q1 2026 results that included 14.5% year-over-year revenue growth, higher subscription and ARR figures, and a new US$550 million term loan alongside repayment of convertible notes. See our latest analysis for Bentley Systems. Despite the solid Q1 update and focus on AI driven workflows, the share price at US$32.93 reflects pressure, with the 90 day share price return down 15.5% and the 1 year total shareholder return down...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

Is CoStar Group (CSGP) Attractive After A 57% Twelve Month Share Price Decline?

If you are wondering whether CoStar Group at around US$33.89 is starting to look like value or still overpriced, the key is to understand what the current share price actually reflects. The stock is roughly flat over the last 7 days at up 0.1% and up 3.4% over the last 30 days, but the longer term picture is much weaker with the share price down 48.4% year to date and down 57.1% over the last 12 months. These declines sit against a backdrop of ongoing attention on CoStar Group's role in real...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Assessing Arcutis Biotherapeutics (ARQT) Valuation After New Genital Psoriasis Clinical Guidance Publication

Arcutis Biotherapeutics (ARQT) is back in focus after supporting a new American Journal of Clinical Dermatology manuscript that provides practical guidance on diagnosing and managing genital psoriasis across age groups, highlighting the company’s role in clinician education. See our latest analysis for Arcutis Biotherapeutics. Despite attention on the new genital psoriasis guidance and recent restricted stock unit grants, Arcutis Biotherapeutics’ share price, at US$21.23, has fallen sharply...
NasdaqGM:EMAT
NasdaqGM:EMATMetals and Mining

Assessing Evolution Metals & Technologies (EMAT) Valuation After Recent Share Price Weakness

Why Evolution Metals & Technologies stock is on investors’ radar Evolution Metals & Technologies (EMAT) has drawn attention after a recent pullback, with the stock down about 30% over the past month and roughly 19% over the past 3 months. With a market value near US$4.0b, revenue of US$1.879m and a net loss of about US$1.0b, the company’s focus on critical materials and advanced manufacturing comes amid ongoing share price pressure. See our latest analysis for Evolution Metals &...
NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Qfin Holdings (QFIN) Is Down 14.1% After Soft Q1 Results And Cautious Q2 Outlook - Has The Bull Case Changed?

Qfin Holdings, Inc. recently reported first-quarter 2026 results showing revenue of CNY 3,909.33 million and net income of CNY 883.32 million, alongside second-quarter net income guidance of RMB 830–910 million. The company also announced that board member Mr. Dan Zhao resigned for personal reasons on June 3, 2026, leaving an eight-person board with six independent directors overseeing its AI-driven credit-tech operations. We’ll now examine how Qfin’s weaker first-quarter earnings and...
NasdaqGS:JOYY
NasdaqGS:JOYYInteractive Media and Services

Does Q2 Guidance And EPS Shift Change The Bull Case For JOYY (JOYY)?

In late May 2026, JOYY Inc. reported first-quarter 2026 results, with revenue of US$555.7 million and net income of US$50.32 million, and issued second-quarter 2026 net revenue guidance of US$562 million to US$581 million, while cautioning that macroeconomic uncertainties could alter these preliminary views. An interesting wrinkle is that while net income fell sharply from a very large prior-year figure, basic earnings per share from continuing operations still increased to US$1, suggesting...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

Assessing Pulse Biosciences (PLSE) Valuation After Strong Recent Share Price Momentum

Why Pulse Biosciences is on investors’ radar Pulse Biosciences (PLSE) has drawn fresh attention after a period of strong share price moves, including gains over the past month and past 3 months that stand out against its recent trading history. See our latest analysis for Pulse Biosciences. Against this backdrop, the recent 32.76% 30-day share price return and 30.23% 90-day share price return sit alongside an 89.17% year-to-date share price gain and a 3-year total shareholder return of...
NasdaqGS:UNIT
NasdaqGS:UNITTelecom

A Look At Uniti Group (UNIT) Valuation As New Fiber Backed Debt Deal Reshapes Its Balance Sheet

Why Uniti Group’s new fiber-backed debt deal matters for shareholders Uniti Group (UNIT) has priced about $1.14b of secured fiber network revenue term notes through subsidiary Kinetic ABS Issuer LLC, backed by residential fiber assets and customer agreements across multiple U.S. states. The company plans to use the proceeds for general corporate purposes, including capital expenditures and repayment of outstanding debt. This directly affects its capital structure, interest costs, and...
NasdaqGS:CNXC
NasdaqGS:CNXCProfessional Services

Concentrix (CNXC) Valuation Revisited As Webhelp Integration Synergies And Debt Management Come Under Closer Review

Concentrix (CNXC) is back in focus as investors weigh how effectively the company can capture expected cost and margin benefits from its Webhelp integration, while also assessing currency exposure and debt in light of recent share price moves. See our latest analysis for Concentrix. The recent 14.63% 1 month share price return contrasts with a 32.49% decline year to date and a 49.06% fall in 1 year total shareholder return, suggesting short term momentum is building while longer term...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

How Perrigo’s Steady 2026 Outlook Amid Soft Sales At Perrigo (PRGO) Has Changed Its Investment Story

Perrigo recently reported past first-quarter 2026 results with adjusted earnings per share above estimates but revenue below expectations, citing softer consumer demand and inventory destocking, while it reaffirmed its full-year 2026 guidance. An interesting aspect is that management kept its outlook intact despite weaker sales trends and broadly lower analyst estimates, underscoring confidence in its current plan. We’ll now assess how Perrigo’s decision to reaffirm full-year guidance...
NasdaqGS:CNOB
NasdaqGS:CNOBBanks

A Look At ConnectOne Bancorp (CNOB) Valuation After Strong Earnings And Institutional Interest

ConnectOne Bancorp earnings and dividend momentum draw investor focus ConnectOne Bancorp (CNOB) recently topped quarterly earnings expectations, sending the stock to a new 52 week high as institutional investors added to positions and dividend metrics attracted fresh attention from income focused investors. See our latest analysis for ConnectOne Bancorp. ConnectOne Bancorp’s recent breakout to a new 52 week high comes after its strong quarterly earnings and increased institutional interest,...
NYSE:USAC
NYSE:USACEnergy Services

How Strong Q1 Results and J-W Power Integration Will Impact USA Compression Partners (USAC) Investors

In early June 2026, USA Compression Partners, LP presented at Bank of America’s Energy & Power Credit Conference and RBC Capital Markets’ Global Energy, Power & Infrastructure Conference in New York, following first-quarter 2026 results that exceeded revenue expectations and reaffirmed full-year guidance. A key insight from these updates is how the J-W Power acquisition and tight compression market are supporting USA Compression’s utilization and contract visibility. Next, we’ll examine...
NasdaqCM:PCT
NasdaqCM:PCTChemicals

PureCycle Technologies (PCT) Valuation Check As Thailand FastPass Approval Supports Rayong Growth Plans

PureCycle Technologies (PCT) is back in focus after its Thailand subsidiary was admitted to the Thailand FastPass Investment Acceleration Program, tying the stock story more closely to its planned Rayong polypropylene recycling facility. See our latest analysis for PureCycle Technologies. The Thailand FastPass news lands after a sharp 112.84% 90 day share price return and a 31.32% 30 day share price return, even though the stock fell 10.29% on the day. A 26.67% 1 year total shareholder return...
NYSE:NPKI
NYSE:NPKITrade Distributors

Assessing NPK International (NPKI) Valuation After Its Recent Rebrand And Share Price Cooldown

NPK International (NPKI), a US based temporary worksite access solutions company, recently completed its rebrand from Newpark Resources, bringing fresh attention to a stock with mixed short term and longer term return profiles. See our latest analysis for NPK International. At a share price of US$14.28, NPK International has cooled in the very short term, with the share price down 2.33% over 1 day and 4.48% over 30 days. However, the year to date share price return of 18.02% and 1 year total...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Does Nuvalent (NUVL) Have the Pipeline Depth to Justify Its Global Expansion Ambitions?

Nuvalent, Inc. recently announced that the U.S. FDA accepted New Drug Applications for its investigational lung cancer therapies neladalkib and zidesamtinib, granting Priority Review to neladalkib and setting target action dates of September 18 and November 27, 2026, respectively. Together with the appointment of Georg Pirmin Meyer, M.D., as Chief International Officer, these milestones highlight Nuvalent’s push to build a global commercial footprint around its late-stage oncology...
NasdaqGM:KOD
NasdaqGM:KODBiotechs

Why Kodiak Sciences (KOD) Is Down 15.4% After Zenkuda’s Phase III GLOW2 Win And Accelerated Filing

Kodiak Sciences recently reported that its Phase III GLOW2 trial of Zenkuda for diabetic retinopathy met primary and key secondary endpoints with strong efficacy, and the company is also advancing multiple late-stage ophthalmology programs while maintaining a solid, debt-free balance sheet. This combination of positive late-stage data and an accelerated regulatory submission plan highlights how central Zenkuda has become to Kodiak’s overall pipeline story. Next, we’ll examine how Zenkuda’s...
NYSE:WY
NYSE:WYSpecialized REITs

Will Q1 Beat And Timberland Sale Reshape Weyerhaeuser's (WY) Higher-Return Portfolio Narrative?

In late April 2026, Weyerhaeuser reported Q1 results that topped expectations, with US$1.73 billion in net sales, US$77 million in adjusted net earnings, and completion of a US$192 million divestiture of 108,000 acres of non-core Virginia timberlands. Beyond the quarterly beat, the sale of lower-priority timberlands and progress in higher-margin Wood Products and Strategic Land Solutions highlight how Weyerhaeuser is reshaping its portfolio toward higher-return uses of its asset base. Next,...
NYSE:NRGV
NYSE:NRGVElectrical

Energy Vault (NRGV) Is Up 8.3% After Accelerating Shift To Integrated Own-And-Operate Model

In recent developments, Energy Vault Holdings reported very large year-over-year revenue growth for fiscal 2025, driven by project execution in Australia and the U.S., the ramp-up of its Asset Vault portfolio, and US$450 million of new strategic financing, while shareholders reelected three Class II directors and ratified BDO USA, P.C. as auditor for the fiscal year ending December 31, 2026. Together, the rapid expansion of contracted capacity to 540 megawatts and the move into AI-focused...
NYSE:FPS
NYSE:FPSElectrical

Does Forgent Power Solutions' (FPS) Massive Equity Raise Hint At A Deeper Capital Structure Reset?

Forgent Power Solutions, Inc. recently completed a follow-on equity offering of approximately US$1.99 billion, issuing 42,280,000 Class A common shares at US$47 each, slightly below the reference price. This capital raise follows the company’s move to reprice its senior credit facilities and target lower interest costs, highlighting an active approach to reshaping its capital structure. We’ll now examine how this large equity raise, alongside the repriced credit facilities, may influence...
NYSE:SPNT
NYSE:SPNTInsurance

How SiriusPoint’s New London Crisis Solutions Platform Could Shape SPNT’s Specialty Risk Profile

SiriusPoint has recently launched a new Crisis Solutions class of business within its London Market Specialty division, appointing experienced underwriters Paul Beattie and Ed Winter as joint Heads of Crisis Solutions to build out underwriting, exposure management and claims capabilities in London. This move expands SiriusPoint’s presence in crisis, terrorism and political violence coverage, complementing its existing marine and specialty lines and broadening its offering for global clients...